Do-Hyung Kim Selected Research

Do-Hyung Kim Research Topics

Disease

15	Infections 07/2022 - 10/2011
6	Neoplasms (Cancer) 08/2021 - 01/2015
6	Starvation 01/2018 - 04/2010
4	Inflammation (Inflammations) 10/2022 - 03/2018
3	Hypoxia (Hypoxemia) 02/2022 - 12/2017
3	Hypertension (High Blood Pressure) 12/2020 - 09/2012
3	Body Weight (Weight, Body) 08/2020 - 03/2018
3	Insulin Resistance 01/2019 - 08/2017
2	Hepatocellular Carcinoma (Hepatoma) 08/2021 - 03/2021
2	Ischemic Stroke 08/2021 - 01/2021
2	Viral Hemorrhagic Septicemia 01/2021 - 09/2013
2	Stroke (Strokes) 01/2021 - 09/2012
2	Obesity 08/2020 - 12/2018
2	Tuberous Sclerosis (Bourneville's Disease) 01/2013 - 10/2011
1	Disease Progression 07/2022
1	Coinfection 11/2021
1	Thromboembolism 08/2021
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2021
1	Viremia 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Immune System Diseases (Immune Disorders) 12/2020
1	Thrombosis (Thrombus) 12/2020
1	Hemolysis 12/2020
1	Bacterial Infections (Bacterial Infection) 12/2020
1	Liver Diseases (Liver Disease) 12/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2020
1	Acute-Phase Reaction 10/2019
1	Wounds and Injuries (Trauma) 10/2019
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 06/2018
1	Status Epilepticus (Complex Partial Status Epilepticus) 12/2017
1	Ischemia 12/2017
1	Hypothermia 12/2017
1	Temporal Lobe Epilepsy 12/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2017
1	Leukemia 11/2017
1	Fatigue 08/2017
1	Hyperlipidemias (Hyperlipidemia) 08/2017
1	Type 2 Diabetes Mellitus (MODY) 08/2017
1	Colorectal Neoplasms (Colorectal Cancer) 05/2017
1	Hyperplasia 02/2016

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 11/2021 - 08/2007
6	Messenger RNA (mRNA)IBA 07/2022 - 10/2011
6	Mechanistic Target of Rapamycin Complex 1IBA 01/2018 - 10/2011
5	Phosphotransferases (Kinase)IBA 01/2018 - 02/2010
2	IronIBA 10/2022 - 08/2015
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 08/2021 - 01/2018
2	Imatinib Mesylate (Gleevec)FDA Link 01/2021 - 04/2013
2	LipidsIBA 08/2020 - 12/2018
2	Amino Acids FDA Link 01/2018 - 06/2012
2	Insulin (Novolin)FDA Link 11/2017 - 01/2013
2	Mechanistic Target of Rapamycin Complex 2IBA 11/2017 - 08/2007
1	HemopexinIBA 10/2022
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 10/2022
1	MicroRNAs (MicroRNA)IBA 07/2022
1	KinesinsIBA 07/2022
1	Protein Isoforms (Isoforms)IBA 02/2022
1	ProteomeIBA 11/2021
1	Oxygen (Dioxygen)IBA 11/2021
1	necrostatin-1IBA 08/2021
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 08/2021
1	manganese ferriteIBA 03/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	erucylphosphocholineIBA 01/2021
1	GTP-Binding Proteins (G-Protein)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Complement System Proteins (Complement)IBA 12/2020
1	Hemoglobins (Hemoglobin)IBA 12/2020
1	Protein AggregatesIBA 12/2020
1	PerforinIBA 12/2020
1	Blood Proteins (Serum Proteins)IBA 10/2019
1	C-Reactive ProteinIBA 10/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Neutralizing AntibodiesIBA 01/2019
1	PowdersIBA 12/2018
1	ferulic acid (sodium ferulate)IBA 12/2018
1	SaltsIBA 12/2018
1	peptidoglycan recognition proteinIBA 06/2018
1	Peptidoglycan (Murein)IBA 06/2018
1	Pattern Recognition ReceptorsIBA 06/2018
1	Collagenases (Collagenase)FDA Link 03/2018
1	KBH-JP-040IBA 03/2018
1	Matrix Metalloproteinases (MMPs)IBA 03/2018
1	Celecoxib (Celebrex)FDA Link 03/2018
1	p38 Mitogen-Activated Protein KinasesIBA 03/2018
1	Glutamine (L-Glutamine)FDA Link 01/2018
1	Class III Phosphatidylinositol 3-KinasesIBA 01/2018
1	Alanine (L-Alanine)FDA Link 01/2018
1	Hypnotics and Sedatives (Sedatives)IBA 12/2017
1	Anticonvulsants (Antiepileptic Drugs)IBA 12/2017
1	TOR Serine-Threonine KinasesIBA 11/2017
1	Cathepsin AIBA 11/2017
1	MelatoninIBA 08/2017
1	CytokinesIBA 08/2017
1	fucoidanIBA 05/2017

Therapy/Procedure

2	Thrombectomy 08/2021 - 01/2021
1	Catheters 08/2021
1	Punctures 01/2021
1	Induced Hypothermia 12/2017
1	Stents 02/2016